Monday 23rd May 2011 1 Comment
|Text too small?|
Investment company Kingfish reported a fall in full year after tax profit to $9.7 million from $24.5 million the year before, while its total shareholder return was 16.3%.
The fall in net profit reflected a lower gain in the fair value of investments of $9.2 million in the year to March, compared to a gain of $22.8 million the year before. Dividend income dropped to $2.6 million from $3.3 million.
The 16.3% total shareholder return, reflected gains in the Kingfish share price and dividends. It compared with a 5.3% return on the NZX50 index, the basket of shares representing this country's top 50 listed companies, the company said.
Kingfish, which invests primarily in listed New Zealand companies, added Kathmandu, Fisher & Paykel Healthcare and Infratil to its portfolio during the year.
Those were funded by trimming the portfolio's investment in several holdings, notably Pumpkin Patch and Delegats' as they faced headwinds in their businesses, Kingfish said.
No holding had suffered a deterioration in prospects large enough for it to be sold out completely.
During the year, net asset value (NAV) per share, adjusted to included dividends, rose 9.8%.
In accordance with the Kingfish policy to pay out 2% of its NAV per quarter, the company said it paid four tax-paid dividends during the year amounting to a total of 8.69c per share. For the first quarter of 2012 the dividend was 2.26cps.
Fisher Funds managing director Carmel Fisher said that after a tough first quarter when Kingfish's adjusted NAV fell 7.2%, the adjusted NAV rose in each of the following three quarters.
New Zealand Rural Land Company Limited (NZX: NZL) Agreement to acquire large scale dairy asset portfolio
EROAD Limited (NZX: ERD) launches Clarity Solo Dashcam
22nd October 2021 Morning Report
Pictor ready to roll out game-changing COVID antibody test in New Zealand
Scott Technology Limited (NZX: SCT) Announces FY21 Results
21st October 2021 Morning Report
Greenfern Industries Limited (NZX: GFI) L&Q Notice
TruScreen Group Limited (NZX: TRU) Clinical Trial Results Highlight Efficacy of TRU Technology
20th October 2021 Morning Report
Freightways Limited (NZX: FRE) Acquisition of ProducePronto